Diabetes

  • Professional photo of Flavia Pease
    Image attribution tooltip
    Retrieved from Insulet on September 16, 2025
    Image attribution tooltip

    Insulet names new CFO; Dexcom CEO on leave

    Flavia Pease will take over as Insulet’s CFO on Sept. 30. Elsewhere, outgoing Dexcom CEO Kevin Sayer is taking a medical leave of absence.

    By • Sept. 16, 2025
  • A black reader is shown on top of a phone with a blood glucose reading.
    Image attribution tooltip
    Permission granted by Senseonics
    Image attribution tooltip

    Senseonics inks deal to bring CGM commercialization back in-house

    BTIG analysts said Senseonics is doubling down on its belief an inflection point in patient demand is imminent, but the company will need a large sales force to win market share.

    By • Sept. 8, 2025
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendline➔
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • Modern office building with tall glass windows and palm trees lining the entry drive. A large white and green sign in the foreground reads “Dexcom” with the number “6350” below. Surrounding the sign are colorful landscaping features including small bushes, flowers, and a mulched bed. Cars and flags are visible in the background.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Dexcom to lay off about 350 people

    The diabetes technology company said the cuts are part of broader changes to its structure, including eliminating operations roles in San Diego and shifting those positions to Arizona.

    By • Sept. 4, 2025
  • A person stands outside wearing a small, square device with a cord on their belt.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic advances Abbott partnership with FDA nod

    The company received FDA authorization to pair its 780G insulin pump with a glucose sensor made by Abbott, and to use the device for Type 2 diabetes.

    By • Sept. 2, 2025
  • Professional photo of Eric Benjamin
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip

    Insulet promotes Eric Benjamin to chief operating officer

    As new CEO Ashley McEvoy works to build the brand globally, the diabetes tech company also hired Manoj Raghunandanan as chief growth officer.

    By • Aug. 26, 2025
  • A box says Luna on the front, with three oval-shaped components in front of it.
    Image attribution tooltip
    Retrieved from Luna Health on August 20, 2025
    Image attribution tooltip

    Luna Health raises $23.6M for tiny insulin patch pump

    The startup intends to make a small patch pump with a closed-loop algorithm for nighttime glucose control.

    By • Aug. 20, 2025
  • A person smiles while wearing a square device on their hip and a round device on their upper arm.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem, Insulet monitoring CMS payment proposal for diabetes tech

    The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for diabetes devices, if finalized.

    By • Aug. 8, 2025
  • A square screen shows a graph of blood glucose levels and a bolus option.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem insulin pump malfunction linked to 59 injuries

     A problem with speakers in Tandem’s t:slim X2 insulin pumps can cause insulin delivery to stop, the company said.

    By • Aug. 7, 2025
  • Modern office building with tall glass windows and palm trees lining the entry drive. A large white and green sign in the foreground reads “Dexcom” with the number “6350” below. Surrounding the sign are colorful landscaping features including small bushes, flowers, and a mulched bed. Cars and flags are visible in the background.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Dexcom raises sales expectations, discusses G8 plans

    Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and over-the-counter devices to drive future growth.

    By • July 31, 2025
  • Professional photo of Kevin Sayer
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom CEO Kevin Sayer to step down

    Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.

    By • Updated July 31, 2025
  • A person holds a phone, wearing a white patch on their forearm and an insulin pump on their hip.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic receives Type 2 label expansion for MiniMed 780G in Europe

    The CE mark also allows Medtronic’s automated insulin delivery system to be used during pregnancy and by children as young as 2.

    By • July 23, 2025
  • Abbott BinaxNOW home COVID-19 test
    Image attribution tooltip

    Abbott

    Image attribution tooltip
    Earnings & Tariffs

    Abbott lowers sales forecast on diagnostics decline, US funding cuts

    Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.

    By • July 17, 2025
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic names CFO for diabetes spinoff

    The company named Chad Spooner CFO of MiniMed ahead of plans to spin out the diabetes unit into a separate public firm.

    By • July 8, 2025
  • A rectangular, metallic device on a catheter sites next to three nickels.
    Image attribution tooltip
    Permission granted by Glucotrack
    Image attribution tooltip

    Implantable glucose monitor competitor emerges with early data

    Glucotrack, which is developing a glucose monitor that is implanted through a minimally invasive surgery, said the small study met safety and performance goals.

    By • July 8, 2025
  • A person eats oatmeal with berries, and a phone on the counter shows their current glucose levels.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Who benefits from over-the-counter CGMs?

    Experts speaking at the ADA’s Scientific Sessions supported making CGMs more accessible, but debated their usefulness for adults without diabetes.

    By • July 1, 2025
  • A person sits on a couch with a white patch on their upper arm and a rectangular device with a screen on their hip.
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    New glucose sensors, insulin patch pumps lead ADA’s Scientific Sessions

    The diabetes conference featured a debate about over-the-counter glucose monitors and updates on upcoming devices, including insulin patch pumps. Here’s a roundup of MedTech Dive’s coverage.

    By • July 1, 2025
  • Professional photo of Elizabeth Gasser
    Image attribution tooltip
    Permission granted by Tandem Diabetes Care
    Image attribution tooltip

    Tandem’s Elizabeth Gasser on patch pump plans, Abbott partnership

    The strategy and product exec said Tandem aims to give patients options and reach more people who haven’t yet used insulin pumps.

    By • June 25, 2025
  • A person holds a phone, wearing a white patch on their forearm and an insulin pump on their hip.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors

    Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared updates on its implantable glucose sensors.

    By • June 24, 2025
  • Professional photo of Eric Benjamin
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip

    Insulet’s Eric Benjamin shares update on automated insulin delivery system

    The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since receiving an expanded indication, and shared an update on plans for a closed-loop system.

    By • June 23, 2025
  • A view of the Chicago skyline.
    Image attribution tooltip
    JMSilva via Getty Images
    Image attribution tooltip

    5 things to watch at the ADA’s Scientific Sessions

    The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for people with Type 2 diabetes and companies debut new devices.

    By • June 20, 2025
  • A black, rectangular device displays a blood glucose reading, while a white patch that says Dexcom One+ is to the right.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom recalls more than 700,000 CGM receivers for lack of audible alarm

    Severe adverse events, including seizure and loss of consciousness, were potentially linked to the issue, based on 56 reports Dexcom received.

    By • Updated June 24, 2025
  • Chris smiles and wears a brown jacket.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip
    Q&A

    Abbott’s new diabetes leader on latest sensors, partnerships and Type 2 coverage

    Ahead of the American Diabetes Association’s Scientific Sessions, Chris Scoggins said Abbott’s ambition is to be the most broadly connected diabetes tech company.

    By • June 12, 2025
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem, Abbott team on insulin delivery with glucose-ketone sensor

    Tandem will integrate its insulin delivery systems with a new dual glucose-ketone sensor being developed by Abbott.

    By • June 10, 2025
  • A closeup of an entryway that reads the Federal Trade Commission.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Owens & Minor spikes $1.36B Rotech buyout over regulatory barriers

    The companies scrapped the merger because securing FTC clearance “proved unviable in terms of time, expense and opportunity.”

    By • June 6, 2025
  • A group of people cheering inside the Nasdaq building, standing behind a podium.
    Image attribution tooltip
    Permission granted by Beta Bionics
    Image attribution tooltip
    Q&A

    Beta Bionics CEO, CFO on how to take a company public

    CEO Sean Saint and CFO Stephen Feider spoke about what’s different now that the company is public and the long journey of pursuing an IPO.

    By • June 2, 2025